- Home
- TNDM vs DFIN Comparison
TNDM vs DFIN Comparison
Compare TNDM & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNDM
- DFIN
- Stock Information
- Founded
- TNDM 2006
- DFIN 1983
- Country
- TNDM United States
- DFIN United States
- Employees
- TNDM N/A
- DFIN N/A
- Industry
- TNDM Medical/Dental Instruments
- DFIN Other Consumer Services
- Sector
- TNDM Health Care
- DFIN Consumer Discretionary
- Exchange
- TNDM Nasdaq
- DFIN Nasdaq
- Market Cap
- TNDM 1.1B
- DFIN 1.2B
- IPO Year
- TNDM 2013
- DFIN N/A
- Fundamental
- Price
- TNDM $19.82
- DFIN $54.43
- Analyst Decision
- TNDM Buy
- DFIN Strong Buy
- Analyst Count
- TNDM 14
- DFIN 3
- Target Price
- TNDM $37.29
- DFIN $68.67
- AVG Volume (30 Days)
- TNDM 1.5M
- DFIN 221.0K
- Earning Date
- TNDM 04-30-2025
- DFIN 04-30-2025
- Dividend Yield
- TNDM N/A
- DFIN N/A
- EPS Growth
- TNDM N/A
- DFIN N/A
- EPS
- TNDM N/A
- DFIN 3.01
- Revenue
- TNDM $982,951,000.00
- DFIN $779,600,000.00
- Revenue This Year
- TNDM $8.91
- DFIN $1.99
- Revenue Next Year
- TNDM $11.04
- DFIN $4.64
- P/E Ratio
- TNDM N/A
- DFIN $18.10
- Revenue Growth
- TNDM 27.65
- DFIN N/A
- 52 Week Low
- TNDM $15.75
- DFIN $37.80
- 52 Week High
- TNDM $53.69
- DFIN $71.01
- Technical
- Relative Strength Index (RSI)
- TNDM 42.87
- DFIN 61.46
- Support Level
- TNDM $20.22
- DFIN $54.04
- Resistance Level
- TNDM $21.99
- DFIN $55.65
- Average True Range (ATR)
- TNDM 0.93
- DFIN 1.14
- MACD
- TNDM -0.33
- DFIN -0.31
- Stochastic Oscillator
- TNDM 2.56
- DFIN 38.14
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.